vs

Side-by-side financial comparison of LENSAR, Inc. (LNSR) and TRANSACT TECHNOLOGIES INC (TACT). Click either name above to swap in a different company.

LENSAR, Inc. is the larger business by last-quarter revenue ($14.3M vs $11.5M, roughly 1.3× TRANSACT TECHNOLOGIES INC). On growth, TRANSACT TECHNOLOGIES INC posted the faster year-over-year revenue change (11.9% vs -3.3%). Over the past eight quarters, LENSAR, Inc.'s revenue compounded faster (28.8% CAGR vs 3.5%).

LENSAR, Inc. is a medical technology company specializing in the development and commercialization of advanced ophthalmic surgical systems. Its proprietary augmented reality-enabled devices deliver high precision for cataract surgery and refractive lens exchange procedures, distributed to ophthalmology clinics, surgical centers and hospitals across North America, Europe and key Asia-Pacific markets.

Roper Technologies, Inc. is a holding company that owns companies in the technology sector.

LNSR vs TACT — Head-to-Head

Bigger by revenue
LNSR
LNSR
1.3× larger
LNSR
$14.3M
$11.5M
TACT
Growing faster (revenue YoY)
TACT
TACT
+15.2% gap
TACT
11.9%
-3.3%
LNSR
Faster 2-yr revenue CAGR
LNSR
LNSR
Annualised
LNSR
28.8%
3.5%
TACT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LNSR
LNSR
TACT
TACT
Revenue
$14.3M
$11.5M
Net Profit
$-1.5M
Gross Margin
36.6%
47.6%
Operating Margin
-34.3%
-10.1%
Net Margin
-10.2%
Revenue YoY
-3.3%
11.9%
Net Profit YoY
92.2%
EPS (diluted)
$-0.09
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LNSR
LNSR
TACT
TACT
Q4 25
$14.3M
$11.5M
Q3 25
$12.8M
$13.2M
Q2 25
$12.3M
$13.8M
Q1 25
$12.3M
$13.1M
Q4 24
$14.8M
$10.2M
Q3 24
$11.8M
$10.9M
Q2 24
$10.7M
$11.6M
Q1 24
$8.6M
$10.7M
Net Profit
LNSR
LNSR
TACT
TACT
Q4 25
$-1.5M
Q3 25
$-3.7M
$15.0K
Q2 25
$-1.8M
$-143.0K
Q1 25
$-27.3M
$19.0K
Q4 24
$-18.7M
Q3 24
$-1.5M
$-551.0K
Q2 24
$-9.0M
$-319.0K
Q1 24
$-2.2M
$-1.0M
Gross Margin
LNSR
LNSR
TACT
TACT
Q4 25
36.6%
47.6%
Q3 25
35.1%
49.8%
Q2 25
43.8%
48.2%
Q1 25
42.7%
48.7%
Q4 24
35.1%
44.2%
Q3 24
38.4%
48.1%
Q2 24
45.5%
52.7%
Q1 24
43.0%
52.6%
Operating Margin
LNSR
LNSR
TACT
TACT
Q4 25
-34.3%
-10.1%
Q3 25
-59.4%
0.1%
Q2 25
-51.2%
-1.9%
Q1 25
-47.2%
-0.1%
Q4 24
-8.7%
-10.3%
Q3 24
-10.5%
-7.7%
Q2 24
-49.4%
-3.8%
Q1 24
-33.0%
-12.2%
Net Margin
LNSR
LNSR
TACT
TACT
Q4 25
-10.2%
Q3 25
-29.1%
0.1%
Q2 25
-14.4%
-1.0%
Q1 25
-222.8%
0.1%
Q4 24
-126.2%
Q3 24
-12.7%
-5.1%
Q2 24
-84.6%
-2.8%
Q1 24
-25.0%
-9.7%
EPS (diluted)
LNSR
LNSR
TACT
TACT
Q4 25
$-0.09
$-0.11
Q3 25
$-0.31
$0.00
Q2 25
$-0.15
$-0.01
Q1 25
$-2.32
$0.00
Q4 24
$-1.62
$-0.80
Q3 24
$-0.13
$-0.06
Q2 24
$-0.79
$-0.03
Q1 24
$-0.19
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LNSR
LNSR
TACT
TACT
Cash + ST InvestmentsLiquidity on hand
$18.0M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$-26.0M
$31.1M
Total Assets
$71.4M
$44.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LNSR
LNSR
TACT
TACT
Q4 25
$18.0M
$20.4M
Q3 25
$16.9M
$20.0M
Q2 25
$20.3M
$17.7M
Q1 25
$25.2M
$14.2M
Q4 24
$22.5M
$14.4M
Q3 24
$18.1M
$11.3M
Q2 24
$14.2M
$11.1M
Q1 24
$17.9M
$10.6M
Stockholders' Equity
LNSR
LNSR
TACT
TACT
Q4 25
$-26.0M
$31.1M
Q3 25
$-25.9M
$31.8M
Q2 25
$-23.1M
$31.3M
Q1 25
$-22.1M
$30.9M
Q4 24
$4.9M
$30.6M
Q3 24
$22.7M
$38.4M
Q2 24
$23.6M
$38.5M
Q1 24
$31.8M
$38.6M
Total Assets
LNSR
LNSR
TACT
TACT
Q4 25
$71.4M
$44.8M
Q3 25
$70.2M
$45.0M
Q2 25
$70.4M
$44.5M
Q1 25
$73.0M
$44.2M
Q4 24
$66.3M
$44.0M
Q3 24
$62.0M
$50.5M
Q2 24
$61.4M
$50.4M
Q1 24
$66.1M
$51.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LNSR
LNSR
TACT
TACT
Operating Cash FlowLast quarter
$618.0K
$609.0K
Free Cash FlowOCF − Capex
$589.0K
FCF MarginFCF / Revenue
5.1%
Capex IntensityCapex / Revenue
0.0%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$7.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LNSR
LNSR
TACT
TACT
Q4 25
$618.0K
$609.0K
Q3 25
$-3.5M
$3.6M
Q2 25
$-5.0M
$3.6M
Q1 25
$-6.9M
$-161.0K
Q4 24
$3.7M
$2.4M
Q3 24
$3.2M
$327.0K
Q2 24
$-3.8M
$636.0K
Q1 24
$-5.3M
$-1.5M
Free Cash Flow
LNSR
LNSR
TACT
TACT
Q4 25
$589.0K
Q3 25
$3.6M
Q2 25
$-5.1M
$3.6M
Q1 25
$-6.9M
$-171.0K
Q4 24
$3.7M
$2.4M
Q3 24
$3.1M
$259.0K
Q2 24
$-3.9M
$499.0K
Q1 24
$-5.3M
$-1.6M
FCF Margin
LNSR
LNSR
TACT
TACT
Q4 25
5.1%
Q3 25
27.1%
Q2 25
-41.3%
25.9%
Q1 25
-56.6%
-1.3%
Q4 24
24.7%
23.2%
Q3 24
26.5%
2.4%
Q2 24
-36.4%
4.3%
Q1 24
-61.6%
-14.9%
Capex Intensity
LNSR
LNSR
TACT
TACT
Q4 25
0.0%
0.2%
Q3 25
0.0%
0.5%
Q2 25
0.6%
0.1%
Q1 25
0.0%
0.1%
Q4 24
0.0%
0.1%
Q3 24
0.2%
0.6%
Q2 24
1.1%
1.2%
Q1 24
0.2%
1.0%
Cash Conversion
LNSR
LNSR
TACT
TACT
Q4 25
Q3 25
242.00×
Q2 25
Q1 25
-8.47×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LNSR
LNSR

Products$12.7M89%
Services$1.6M11%

TACT
TACT

Segment breakdown not available.

Related Comparisons